When primary hyperparathyroidism comes as good news

Autor: Eliana Piantanida, Linda Gentile, Luigi Bartalena, Ilaria Marcon, S Rosetti, Daniela Gallo, Maria Laura Tanda, Giuseppe Perrucchini, Antonina Parafioriti, Graziella Pinotti, Bohdan Patera, Elisabetta Armiraglio

Publikováno v: Endocrinology, Diabetes & Metabolism Case Reports, Vol 1, Iss 1, Pp 1-6 (2020)
Endocrinology, Diabetes & Metabolism Case Reports

Summary Brown tumors are osteoclastic, benign lesions characterized by fibrotic stroma, intense vascularization and multinucleated giant cells. They are the terminal expression of the bone remodelling process occurring in advanced hyperparathyroidism

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4424ab6af52d0fa22852f3a5a7c3e93b
https://edm.bioscientifica.com/view/journals/edm/2020/1/EDM20-0046.xml

Primary adrenal lymphoma as a cause of adrenal insufficiency, a report of two cases

Autor: Maria Adele Mastroianni, Kristian Løvås, Kaja Grønning, Ingrid Nermoen, Eystein S. Husebye, Bo Daniel Karlsson, Archana Sharma

Publikováno v: Endocrinology, Diabetes & Metabolism Case Reports, Vol 1, Iss 1, Pp 1-5 (2020)
Endocrinology, Diabetes & Metabolism
Endocrinology, Diabetes & Metabolism Case Reports

Summary Primary adrenal lymphoma (PAL) is a rare cause of adrenal insufficiency. More than 90% is of B-cell origin. The condition is bilateral in up to 75% of cases, with adrenal insufficiency in two of three patients. We report two cases of adrenal

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d971811ab09cb9a0ac1c1071146ffe0
https://edm.bioscientifica.com/view/journals/edm/2020/1/EDM19-0131.xml

Pembrolizumab-induced fulminant type 1 diabetes with C-peptide persistence at first referral

Autor: Yuzo Mizuno, Saya Suzuki, Kazuhisa Kusuki

Publikováno v: Endocrinology, Diabetes & Metabolism Case Reports
Endocrinology, Diabetes & Metabolism Case Reports, Vol 1, Iss 1, Pp 1-5 (2020)

Summary A 72-year-old man with no history of diabetes was referred to our department due to hyperglycemia during pembrolizumab treatment for non-small-cell lung carcinoma. His blood glucose level was 209 mg/dL, but he was not in a state of ketosis or

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68a236e6645f0bdc6e6b7df79d20ed1c
http://europepmc.org/articles/PMC7219158

The complicated clinical course in a case of atypical lipodystrophy after development of neutralizing antibody to metreleptin: treatment with setmelanotide

Autor: Simeon I. Taylor, Diana Rus, Adam H. Neidert, Rita Hench, Baris Akinci, Rasimcan Meral, Frank DiPaola, Elif A. Oral, Maria Westerhoff

Publikováno v: Endocrinology, Diabetes & Metabolism Case Reports, Vol 1, Iss 1, Pp 1-9 (2020)
Endocrinology, Diabetes & Metabolism Case Reports

Summary A patient with atypical partial lipodystrophy who had a transient initial response to metreleptin experienced acute worsening of her metabolic state when neutralizing antibodies against metreleptin appeared. Because her metabolic status conti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::057579038ac17c089add829235048d8f
https://doi.org/10.1530/edm-19-0139

Significant cardiac disease complicating Graves’ disease in previously healthy young adults

Autor: Ravikumar Ravindran, N Ubaysekara, S Rice, J K Witczak, Lakdasa Premawardhana, Z Yousef

Publikováno v: Endocrinology, Diabetes & Metabolism Case Reports
Endocrinology, Diabetes & Metabolism Case Reports, Vol 1, Iss 1, Pp 1-6 (2020)

Summary Graves’ disease is associated with tachydysrythmia, cardiac ischaemia and cardiomyopathy – all uncommon in young adults without previous cardiac disease. We present three young individuals who developed cardiac complications after periods

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86dd15eb77f9fa4338ae247434892a20
http://europepmc.org/articles/PMC6993248